Literature DB >> 19015442

Time course of episodes of definitive vertigo in Meniere's disease.

Herminio Perez-Garrigues1, Jose A Lopez-Escamez, Paz Perez, Ricardo Sanz, Miguel Orts, Jaime Marco, Rafael Barona, Mari C Tapia, Ismael Aran, Carlos Cenjor, Nicolas Perez, Constantino Morera, Rafael Ramirez.   

Abstract

OBJECTIVE: To evaluate the frequency and duration of episodes of definitive vertigo in Ménière's disease.
DESIGN: Prospective longitudinal study.
SETTING: Multiple tertiary referral centers. PATIENTS: Five hundred ten individuals from 8 hospitals that met the American Academy of Otolaryngology-Head and Neck Surgery diagnostic criteria for definitive Ménière's disease. INTERVENTION: Conservative treatment. MAIN OUTCOME MEASURE: Frequency and duration of episodes of definitive vertigo during follow-up.
RESULTS: Ménière's disease affects both sexes and both ears equally, with onset generally in the fourth decade of life. The number of episodes of vertigo is greater in the first few years of the disease. Although episodes of vertigo that last longer than 6 hours are less frequent than shorter episodes, they occur with similar frequency throughout the natural course of the disease. The percentage of patients without episodes of vertigo increases as the disease progresses, and 70% of patients who did not have an episode of vertigo for 1 year will continue to be free of episodes during the following year. Thus, there is a relationship between the frequency of episodes in consecutive years, although this association decreases rapidly as the number of years increases.
CONCLUSION: The frequency of definitive episodes of vertigo in Ménière's disease decreased during follow-up, and many individuals reached a steady-state phase free of vertigo.

Entities:  

Mesh:

Year:  2008        PMID: 19015442     DOI: 10.1001/archotol.134.11.1149

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  15 in total

Review 1.  [Diagnostic criteria for Menière's disease according to the Classification Committee of the Bárány Society].

Authors:  J A Lopez-Escamez; J Carey; W-H Chung; J A Goebel; M Magnusson; M Mandalà; D E Newman-Toker; M Strupp; M Suzuki; F Trabalzini; A Bisdorff
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

Review 2.  Medical management of Ménière's disease: a 10-year case series and review of literature.

Authors:  C Martín González; F M González; A Trinidad; A Ibáñez; M Pinilla; A Martínez Ruiz-Coello; A Rodríguez Valiente; C López-Cortijo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-08       Impact factor: 2.503

Review 3.  Migraine-associated vertigo: diagnosis and treatment.

Authors:  Yoon-Hee Cha
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

4.  Therapeutic illusion: another frontier in Ménière's disease.

Authors:  Nicolas Pérez-Fernández; Eduardo Martín-Sanz
Journal:  Ann Transl Med       Date:  2016-10

5.  Genetics of recurrent vertigo and vestibular disorders.

Authors:  Irene Gazquez; Jose A Lopez-Escamez
Journal:  Curr Genomics       Date:  2011-09       Impact factor: 2.236

6.  High prevalence of systemic autoimmune diseases in patients with Menière's disease.

Authors:  Irene Gazquez; Andres Soto-Varela; Ismael Aran; Sofia Santos; Angel Batuecas; Gabriel Trinidad; Herminio Perez-Garrigues; Carlos Gonzalez-Oller; Lourdes Acosta; Jose A Lopez-Escamez
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

7.  Video-head impulse test results in patients with Menière's disease related to duration and stage of disease.

Authors:  B F van Esch; K Abolhosseini; S Masius-Olthof; H J van der Zaag-Loonen; P P G van Benthem; Tj D Bruintjes
Journal:  J Vestib Res       Date:  2018       Impact factor: 2.354

8.  Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.

Authors:  Bo Liu; Yangming Leng; Renhong Zhou; Jingjing Liu; Dongdong Liu; Su-Lin Zhang; Wei-Jia Kong
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

9.  Clinical Subgroups in Bilateral Meniere Disease.

Authors:  Lidia Frejo; Andres Soto-Varela; Sofía Santos-Perez; Ismael Aran; Angel Batuecas-Caletrio; Vanesa Perez-Guillen; Herminio Perez-Garrigues; Jesus Fraile; Eduardo Martin-Sanz; Maria C Tapia; Gabriel Trinidad; Ana María García-Arumi; Rocío González-Aguado; Juan M Espinosa-Sanchez; Pedro Marques; Paz Perez; Jesus Benitez; Jose A Lopez-Escamez
Journal:  Front Neurol       Date:  2016-10-24       Impact factor: 4.003

10.  Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).

Authors:  Christine Adrion; Carolin Simone Fischer; Judith Wagner; Robert Gürkov; Ulrich Mansmann; Michael Strupp
Journal:  BMJ       Date:  2016-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.